We are live on ! Find out more
ANIP icon

ANI Pharmaceuticals

172 hedge funds and large institutions have $662M invested in ANI Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 72 increasing their positions, 25 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

309% more first-time investments, than exits

New positions opened: 45 | Existing positions closed: 11

188% more repeat investments, than reductions

Existing positions increased: 72 | Existing positions reduced: 25

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

61% more capital invested

Capital invested by funds: $411M → $662M (+$251M)

25% more funds holding

Funds holding: 138172 (+34)

22% more call options, than puts

Call options by funds: $1.46M | Put options by funds: $1.2M

1.69% more ownership

Funds ownership: 59.4%61.09% (+1.7%)

Holders
172
Holders Change
+34
Holders Change %
+24.64%
% of All Funds
2.7%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
45
Increased
72
Reduced
25
Closed
11
Calls
$1.46M
Puts
$1.2M
Net Calls
+$258K
Net Calls Change
+$318K
Name Holding Trade Value Shares
Change
Change in
Stake
SG Americas Securities
176
SG Americas Securities
New York
-$272K -6,845 Closed
SFS
177
Sowell Financial Services
Arkansas
-$235K -5,926 Closed
XT
178
XTX Topco
Cayman Islands
-$229K -5,763 Closed
SFM
179
Systematic Financial Management
New Jersey
-$68.2K -1,716 Closed
ACM
180
Aquatic Capital Management
Illinois
-$28K -700 Closed
AAS
181
Ameritas Advisory Services
Nebraska
-$1.63K -41 Closed
TWA
182
TCI Wealth Advisors
Arizona
-$715 -18 Closed